{"version":"1.0","type":"link","title":"Impact of antiemetic prophylaxis on reducing trastuzumab deruxtecan dose modifications in HER2+/HER2-low breast cancer.","author_name":"Shin J 외","author_url":"https://prs-insight.online/author/Shin%20J","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/86858","thumbnail_width":1200,"thumbnail_height":630}